Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.
Study reference: NCT06365021. HopeStage can help you review the study, but cannot decide medical eligibility.
RecruitingNCT06365021
ACT for Syndromic and Subsyndromic Depression in Bipolarity
This study is recruiting. It focuses on bipolarity and currently lists participation information in Brazil.
BipolarityOtherFrom 18 Years to 65 Years
Key information made simple
This study is looking at whether psychoeducation can help people with bipolarity. Participants receive a study treatment and complete follow-up visits and assessments. Taking part may give some people access to psychoeducation, but direct benefit is not guaranteed.
Your next step
The official record suggests a mix of remote and in-person participation through a hospital, with sites including Tatiana Cohab Khafif in São Paulo. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually matching the main diagnosis and being able to follow the planned visits or tasks, while common reasons not to take part include other factors that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Sponsor
- Beny Lafer
- Sponsor type
- Unknown or unclear
- Main activity
- medication or study treatment
- Intervention
- Not available
- Time commitment
- long follow-up or multiple visits
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Recruiting
- Source
- Official registry link
Key study information
- Official title
- ACT for Syndromic and Subsyndromic Depression in Bipolarity
- Condition
- Bipolarity
- Study status
- Recruiting
- Sponsor / lead affiliation
- Beny Lafer
- Location / country
- Brazil
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT06365021
Why this study may matter
This study may matter because it adds public evidence around bipolarity. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help improve understanding of your condition.
It requires regular follow-up, often through questionnaires or interviews.
Mixes in-person and remote participation.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- ACT for Syndromic and Subsyndromic Depression in Bipolarity
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT06365021
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is ACT for Syndromic and Subsyndromic Depression in Bipolarity?
This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Beny Lafer. We could not clearly classify the sponsor type from the available data. Check the official source record to verify who is responsible for the study.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve medication or study treatment, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me